WHO BUDGET CRISIS IMPACT ON STAFF

5 April 1992

Staff of the World Health Organiz-ation, as a result of the budget crisis, are "deeply concerned not only about their individual futures, but indeed, about te future of the Organization," according to Sue Shaw, chairman of the WHO staff committee.

In addition, she said, the current restructuring of the United Nations under the new Secretary General has reduced the number of top-echelon staff in the UN.

During what is described as a "lively session" of a staff committee meeting with the WHO administration, employees were told that the projected budget deficit for the biennium is $46 million for Geneva alone. There is an internal borrowing facility of $80 million, "but it would not be prudent financial management to use it to cover the entire deficit." Therefore, the staff were advised that only $33 million will be taken from these and other sour- ces, leaving $13 million still to be found.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight